This prospective randomized study aims to determine the influence of the use of local hemostatic on the incidence of local complications derived from the edge of transection: biliary fistula or bleeding, after scheduled hepatic resection.
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Bleeding
Timeframe: Day 0 to day 30 (+-10 days)
Presence of Biliary Fistula
Timeframe: Day 0 to day 30 (+-10 days)